Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cryptogenic Fibrosing Alveolitis

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kalafatis, D1
Joshua, V1
Hansson, M1
Mathsson-Alm, L1
Hensvold, A1
Sköld, M1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cryptogenic Fibrosing Alveolitis

ArticleYear
Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosis.
    Respirology (Carlton, Vic.), 2023, Volume: 28, Issue:10

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Arthritis, Rheumatoid; Autoantibodies; Fib

2023